C07D 473/38
Attached in position 6
Official title: attached in position 6
C07D473/38 (Attached in position 6) appears on 99 US grants and 78 published applications in this corpus.
Search patents in C07D- Granted patents
- 99
- Published applications
- 78
- Assignees
- 77
- Inventors
- 266
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 3 | 8 |
| 2004 | 3 | 6 |
| 2005 | 4 | 3 |
| 2006 | 1 | 3 |
| 2007 | 1 | 3 |
| 2008 | 2 | 4 |
| 2009 | 3 | 1 |
| 2010 | 1 | 2 |
| 2011 | 2 | 2 |
| 2012 | 1 | 5 |
| 2013 | 2 | 0 |
| 2014 | 5 | 8 |
| 2015 | 2 | 3 |
| 2016 | 4 | 3 |
| 2017 | 3 | 6 |
| 2018 | 4 | 1 |
| 2019 | 4 | 5 |
| 2020 | 3 | 3 |
| 2021 | 1 | 2 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 3 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- PARP inhibitors for treating cancer and asthma2 Sep 2025US 12,404,250 B2Oregon Health & Science University
- PARP inhibitors for treating cancer and asthma9 Jul 2024US 12,030,858 B2Oregon Health & Science University
- Medicament for liver regeneration and for treatment of liver failure7 May 2024US 11,975,032 B2Medizinische Hochschule Hannover
- Kinase modulators2 Jan 2024US 11,858,907 B2Rhizen Pharmaceuticals SA
- Electroplating composition and electroplating method15 Jun 2021US 11,035,050 B2
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- Heterocyclic Compounds as ENT Inhibitors and Compounds for Use in the Treatment of Cancers2 Jul 2026US 2026/0184712 A1iTeos Belgium SA
- Anticancer drug conjugates4 Jun 2026US 2026/0151413 A1Ariel Scientific Innovations Ltd.
- Parp inhibitors for treating cancer and asthma12 Dec 2024US 2024/0409518 A1Oregon Health & Science University
- Novel kinase modulators31 Oct 2024US 2024/0360095 A1Rhizen Pharmaceuticals SA
Most cited
By later US patents
- Inhibitors of human phosphatidylinositol 3-kinase delta181US 6,518,277 B1ICOS Corporation · 2003
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Inhibitors of human phosphatidylinositol 3-kinase delta145US 6,800,620 B2ICOS Corporation · 2004
- Inhibitors of human phosphatidyl-inositol 3-kinase delta138US 6,949,535 B2ICOS Corporation · 2005
- Methods and compositions for treating viral infections and guanine acyclic nucleosides135US 4,199,574 ABurroughs Wellcome Co. · 1980